Label

How We Work

Grant

Back

Print

PATH Drug Solutions


March 2005
to support the Phase III drug development program for visceral leishmaniasis
$11,686,692
71
Global Health and Development Public Awareness and Analysis
GLOBAL|ASIA
Global Health
San Francisco, California
http://sites.path.org/drugdevelopment/

Visit Our Blog